Skip to main content
. Author manuscript; available in PMC: 2020 Aug 6.
Published in final edited form as: Cornea. 2020 Aug;39(8):1013–1016. doi: 10.1097/ICO.0000000000002311

TABLE 3.

Sensitivity and Specificity for Each Keratoconjunctivitis Sicca Clinical Sign or Test in the Entire Cohort With OSS Separated Into Its Components, Lissamine and Fluorescein

Ocular Clinical Sign or Test Sensitivity (95% CI) Specificity (95% CI)
TBUT < 10 s 98.9% (97.7%–99.5%) 29.1% (26.5%–31.7%)
Fluorescein ≥ grade 3 82.6% (78.9%–85.7%) 88.8% (85.3%–91.6%)
Lissamine ≥ grade 3 90.5% (87.2%–93.0%) 73.0% (69.6%–76.2%)
Schirmer I ≤ 5 mm/5 min 49.8% (46.7%–52.9%) 88.1% (86.1%–89.8%)